-
-
-
-
-
-
-
SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS
-
-
-
-
-
-
-
Sera Prognostics (SERA) Announces CEO Retirement, Appoints Zhenya Lindgardt as Interim CEO
-
-
-
-
-
-
-
Sera Prognostics (SERA) Announces Positive Top-line Data from AVERT PRETERM TRIAL
-
-
-
-
-
-
-
BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRMĀ® TEST TO COVERED PREGNANT MEMBERS
-
-
-
-
-
-
-
Sera Prognostics Presents Data Demonstrating Prediction of Preeclampsia Utilizing Protein Biomarker and Clinical Factors at SRI Annual Meeting
-
-
-
-
-
-
-
SERA PROGNOSTICS ADDED TO NASDAQ BIOTECHNOLOGY INDEX
-
-
-
-
-
-
-
Sera Prognostics Announces The Appointment Of Zhenya Lindgardt To The Board
-
51,659 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All